NYSE$AVD

American Vanguard Corporation · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Reported flat quarterly sales despite global destocking, with a rebound expected in Q4 and a transformation plan underway.

American Vanguard reported Q3 2023 financial results, showing net sales of $149.5 million, which is in line with the prior year. However, the company experienced a net loss of $325 thousand, a significant decrease compared to the net income of $6.7 million in Q3 2022. The company is implementing a transformation plan to improve future growth, operational efficiency, and profitability.

  • Q3 sales were in line with the prior year despite global destocking by customers.
  • Strong sales were recorded for the premier corn soil insecticide Aztec and soil fumigants in the Pacific Northwest.
  • US non-crop business is seeing more normalized trends in nursery, ornamental, and professional products.
  • International businesses are still feeling the effects of low-priced generic products in certain regions, especially Central America, while Mexico and Australia remain strong.

Headline financials

Total Revenue

$150M

Previous: $152M-1.7%
EPS (adj)

-$0.01

Previous: $0.23-104.3%
Gross Margin

29.0%

No prior period
Capital Expenditures

-$8.59M

Previous: -$8.95M+4.0%
Free Cash Flow

-$8.91M

Previous: -$2.21M-304.3%
Net Income

-$325K

Previous: $6.74M-104.8%
Operating Income

$4.19M

Previous: $11.2M-62.7%
Gross Profit

$43.1M

Previous: $61.4M-29.8%
Cash & Equivalents

$11.5M

Previous: $20.8M-44.6%
Total Assets

$803M

Previous: $776M+3.4%
R&D Expense

$0.00

No prior period
Stock-Based Comp

$1.72M

Previous: $1.56M+10.0%

Revenue & EPS history

American Vanguard · Revenue · Quarterly

$150M

Q3 2023-1.7%vs Q3 2022
Beat estimate in 5 of 13 quarters(38%)
ActualEstimate

Revenue by segment

American Vanguard · $150M total across 3 segments · Q3 2023

  • U.S. Crop
    $67.7M-2.0%
  • International
    $62.5M-2.4%
  • U.S. Non-Crop
    $19.3M+1.7%

Forward guidance

The company anticipates improved sales and profitability in the fourth quarter as compared to the first nine months of this fiscal year. They are targeting full year 2023 net sales of $580 million - $590 million, a gross margin of 30%-32%, and an adjusted EBITDA of $55 million - $59 million.

Tailwinds

  • Strong sales are being experienced, particularly within the US Crop business early in the fourth quarter.
  • Customers are making commitments to qualify for program discounts, including early pay.
  • There is stronger US crop demand.
  • US non-crop demand is more normalized.
  • Commodity prices remain relatively stable.

Headwinds

  • International pressure continues.
  • The company identified approximately $15 million in operating profit and interest savings.
  • Higher interest expense.
  • The company is negotiating an expansion of their financial covenants.
  • The company is in a period that calls for more effort, more innovation and more openness to change.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

-1.0%

Avg return

Earnings day

-3.0%

Avg return

5 days after

-2.6%

Avg return

30 days after

52%

34 / 65 earnings

Positive

+18.9%

Q4 2015

Best reaction

-34.9%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.4%-1.0%-9.8%
Q4 2025-9.6%-30.9%-24.6%
Q3 2025-0.8%-0.4%-14.9%
Q1 2025-9.2%-8.5%-19.2%
Q4 2024-5.7%+6.2%-20.0%
Q3 2024+2.1%+5.0%-5.7%
Q2 2024-34.9%-28.5%-20.5%
Q1 2024-26.6%-30.6%-30.4%
Q4 2023+15.3%+9.4%+4.5%
Q3 2023+1.1%-12.3%+5.1%
Q2 2023-16.6%-13.1%-24.7%
Q1 2023-12.9%-9.9%-3.1%
Q4 2022+4.9%+5.5%+7.8%
Q3 2022-4.4%-6.6%-4.8%
Q2 2022-18.2%-15.5%-19.8%
Q1 2022+5.6%-4.5%+17.9%
Q4 2021+2.6%+6.5%+24.0%
Q3 2021+4.3%+3.0%-9.2%
Q2 2021-0.7%-6.6%-3.5%
Q1 2021-3.3%-5.8%-14.6%
Q4 2020+2.1%-2.0%-8.6%
Q3 2020+9.2%+8.3%+21.8%
Q2 2020+4.6%+3.0%+1.0%
Q1 2020-1.9%-9.6%-3.1%
Q4 2019-4.6%-9.3%+2.3%
Q3 2019+5.0%+6.4%+8.4%
Q2 2019+5.4%+3.0%+13.8%
Q1 2019-0.3%-8.3%-19.6%
Q4 2018+6.2%-1.1%-2.1%
Q3 2018-5.6%-1.9%-7.5%
Q2 2018-4.2%-9.3%-4.0%
Q1 2018+11.7%+0.9%+10.5%
Q4 2017+16.0%+15.5%+9.8%
Q3 2017-6.1%-10.1%-10.8%
Q2 2017+9.7%+13.1%+10.0%
Q1 2017+10.9%+9.1%+9.4%
Q4 2016-4.0%-6.2%+4.7%
Q3 2016+0.3%+3.3%+14.3%
Q2 2016+17.6%+16.2%+12.2%
Q1 2016-21.8%
Q4 2015+18.9%
Q3 2015+14.0%
Q2 2015+0.8%
Q1 2015+14.6%
Q4 2014-1.7%
Q3 2014+6.4%
Q2 2014+2.6%
Q1 2014-13.1%
Q4 2013-4.3%
Q3 2013+8.9%
Q2 2013+3.3%
Q1 2013+7.7%
Q4 2009+0.2%
Q4 2012-11.0%
Q3 2012+1.7%
Q2 2012+12.5%
Q1 2012+4.1%
Q4 2011+2.0%
Q3 2010-6.8%
Q3 2011-6.8%
Q2 2010-15.6%
Q1 2011-15.6%
Q2 2011-15.6%
Q4 2010-15.6%
Q1 2010+4.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro